Results from the Phase II clinical trial (NCT02970942) showed that after 72 weeks, 59% of patients in the 0.4 mg semaglutide group achieved NASH resolution without worsening liver fibrosis , a statistically significant result compared to 17% in the placebo group, meeting the primary clinical endpoint
Common Injection Mistakes Injecting cold medication straight from the fridge
Unreconstituted powder is generally more stable at room temperature than the reconstituted solution, which is one reason some compounding pharmacies ship in lyophilized form
Combining genetic insights with clinical assessmentincluding your actual weight loss response at 4-8 weeks, gastrointestinal tolerance, and your provider's evaluationcan help guide more personalized dosing decisions and realistic outcome expectations
NASH occurs when fat deposits cause the liver to become swollen and damaged
Does semaglutide make protein harder to digest